ClinicalTrials.gov
public full text
Public Domain
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
A study to compare Human Inhalation Powder (also known as AIR® Inhaled Insulin) (AIR® is a registered trademark of Alkermes, Inc.)with insulin glargine injections in patients with Type 2 diabetes who are currently taking oral medications and have not previously taken insulin. Change in HbA1c levels will be reviewed to determine superiority or inferiority of the AIR Inhaled Insulin regimen.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes#899279
- Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD#1072783
- Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma#897893
- Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes#141205
- A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus)#904463
Record · ID 1407847
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive